Therapeutic proteins such as insulin or monoclonal antibodies are manufactured in bacteria, yeast, or mammalian cells. Many proteins, however, cannot be expressed in these cells because they are too large or toxic to the cells that produce them. The mission at Dnano is to replace cell-based protein manufacturing with an easier and cheaper cell-free method. The company’s P-Gel (short for protein producing gel) promises to generate high yields of new proteins at lower costs. The scientists at Dnano predict that the P-gel platform will transform protein production into simple solid-state chemical reactions, similar to how PCR improved DNA synthesis.
The company’s name represents its ability to blend DNA and nanotechnology. Co-founder and CSO Dan Luo, Ph.D., views DNA not only as a genetic material, but also as a generic material. “The natural shape of DNA is a scaffold,” Dr. Luo says. He took advantage of the structure to build hydrogels made entirely from DNA and water, where linear DNA molecules are crosslinked with branched DNA to form a 3-D matrix. Then Dr. Luo’s team pioneered ways to exploit DNA’s inherent genetic functions.
They discovered that genes could be dropped inside the hydrogel without encapsulating them. “We have the luxury of linking genes to the gel matrix because both are made of DNA,” adds Dr. Luo, “and DNA ligates with DNA easily.” This feature makes the P-gel system unique.
The DNA sequences within the P-gel easily join to the ends of plasmids that code for a desired protein. Plasmids with genes for this protein are integrated throughout the P-gel. Genes locked into the P-gel are protected from damage. To increase the surface area for reaction, tiny drops of the P-gel are molded into pads about one square millimeter by 20 microns thick. Several hundred pads are placed in a solution of amino acids and protein-making machinery such as ribosomes extracted from living cells. Because genes are packed close together, enzymes taking part in the transcription process remain close by and perform quickly.
Genes concentrate in the P-gel at much higher levels than they can in solution, where DNA precipitates out, Dr. Luo says. “The gel gives higher yields and expression advantages,” says Alan Biloski, Ph.D., co-founder and CEO. According to the company, researchers at Dnano have produced 16 functional proteins in the P-gel at yields 300 times higher than current solution-based methods. The manufactured proteins include reporter proteins such as green fluorescent protein (GFP), kinases, light- and heavy-chain antibodies, hormones, highly repetitive proteins, and membrane proteins. All were successfully produced with complete fidelity of amino acid sequences and full functionality, Dr. Biloski says.
Dnano does not intend to manufacture and sell proteins like GFP, which are made cheaply in cell-based systems. The production of GFP in the P-gel was done as a proof of concept. “If you can produce proteins in bacteria, that’s the cheapest way to go,” comments Dr. Biloski.
Enzymes used in detergents, for instance, are made in bacteria for about $1 per gram, “and we can’t compete with that,” he adds. Instead, Dnano plans to capture the market for the thousands of proteins that cannot be expressed in bacteria to bring totally new proteins to the market.